DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Cost-Effectiveness of Two Painkillers for Treating Pain After Limb Injuries: Randomised Controlled Trial

Information source: Chinese University of Hong Kong
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Soft Tissue Injuries

Intervention: Paracetamol (Drug); Ibuprofen (Drug); Paracetamol Placebo (Drug); Ibuprofen placebo (Drug)

Phase: Phase 2

Status: Recruiting

Sponsored by: Chinese University of Hong Kong

Official(s) and/or principal investigator(s):
Colin A Graham, Principal Investigator, Affiliation: Chinese University of Hong Kong

Overall contact:
Colin A Graham, Phone: 85-22-632-1033, Email: cagraham@cuhk.edu.hk

Summary

Background: Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are commonly used oral analgesics in emergency departments (ED) not only in Hong Kong but throughout the world. There are no large-scale (n>100), prospective, randomised studies comparing paracetamol with ibuprofen in the management of acute soft tissue injury.

As paracetamol is cheaper than most NSAIDs, may be as effective in the management of acute pain and possibly with fewer adverse effects, a large-scale, randomised, controlled trial is needed to answer questions of relative analgesic efficacy, safety and cost-effectiveness. Previous comparative studies on NSAIDS have been done in this unit and have suggested equivalence between two NSAIDs and paracetamol, but numbers were small and drug doses were modest.

Objective: To compare the efficacy, safety and cost between oral ibuprofen and paracetamol in pain control for acute soft tissue injuries in an ED setting

Design: Prospective, double-blind, randomised controlled trial with three arms: oral paracetamol with placebo; oral ibuprofen with placebo; paracetamol and ibuprofen in combination

Participants: 783 subjects having sustained isolated soft tissue limb injury without significant fracture presenting to the ED of Prince of Wales Hospital

Main outcome measures: Pain relief profiles of paracetamol, ibuprofen and the combination of both; adverse effect profiles of paracetamol, ibuprofen and the combination of both; overall cost effectiveness of paracetamol, ibuprofen and the combination of both from the perspective of the healthcare provider

Clinical Details

Official title: Cost-Effectiveness Analysis of Oral Paracetamol and Ibuprofen for Treating Pain After Soft Tissue Limb Injuries: Double-Blind, Randomised Controlled Trial

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Single Group Assignment, Efficacy Study

Primary outcome: analgesic efficacy both at rest and with movement

Secondary outcome: presence, frequency and duration of adverse effects; cost-effectiveness analysis; patient satisfaction with analgesia

Eligibility

Minimum age: 16 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- All patients >16 years presenting to the ED with isolated soft tissue injury without

significant fracture

- between 9am to 5pm, Monday to Friday,

Exclusion Criteria:

- History of :

- peptic ulceration or hemorrhage

- recent anticoagulation

- pregnancy

- adverse reaction to paracetamol or ibuprofen

- renal or cardiac failure

- hepatic problems

- rectal bleeding

- chronic NSAID consumption

- asthma

- chronic obstructive pulmonary disease

- chronic pain syndromes

- prior treatment with analgesia for the same injury

- physical, visual or cognitive impairment making use of the visual analogue scale

unreliable

Locations and Contacts

Colin A Graham, Phone: 85-22-632-1033, Email: cagraham@cuhk.edu.hk

Prince of Wales Hospital, Sha Tin, NT, Hong Kong; Recruiting
Colin A Graham, Principal Investigator
Additional Information

Starting date: January 2005
Ending date: December 2008
Last updated: May 8, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009